Literature DB >> 6225584

Induction of suppressor cell activities in normal lymphocytes by sera from gastric cancer patients.

T Toge, M Tanada, K Yajima, H Kohno, E Itagaki, T Hattori.   

Abstract

Inductions of suppressor cell activities in normal lymphocytes by sera from 154 patients with primary gastric cancer were investigated. Sera from patients with advanced cancer induced suppressor cells which significantly depressed the proliferative responses of autologous responder lymphocytes, while those from early cancer did not. An increase in OKT8 reactive T cell populations in normal lymphocytes occurred rather than a decrease in OKT4 reactive T cells after stimulation with sera as well as concanavalin A in relation to the increase of suppressor cell activities. Furthermore, sera-induced suppressor cell activities apparently correlated with spontaneous suppressor cell activities in cancer donors and both of these activities declined after plasma exchange. These results suggest that sera from gastric cancer patients may contain factors which can induce such suppressor cell activities and that serum factors may activate the suppressor precursors to be spontaneous suppressor cells in vivo in a manner similar to that seen in vitro.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6225584      PMCID: PMC1536177     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Effector and suppressor lymphoid cells in tumor-bearing guinea-pigs.

Authors:  I Berczi; A H Sehon
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

2.  The role of circulating antigen as an inhibitor of tumour immunity in man.

Authors:  G Currie
Journal:  Br J Cancer Suppl       Date:  1973-08

3.  The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.

Authors:  M E Gershwin; J J Castles; A Ahmed; R Makishima
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

4.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

5.  The possible role of prostaglandins in mediating immune suppression by nonspecific T suppressor cells.

Authors:  A M Fulton; J G Levy
Journal:  Cell Immunol       Date:  1980-06       Impact factor: 4.868

6.  Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.

Authors:  S A Huber; G Bigi; Z J Lucas
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

7.  Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.

Authors:  A Yu; H Watts; N Jaffe; R Parkman
Journal:  N Engl J Med       Date:  1977-07-21       Impact factor: 91.245

8.  Concanavalin A-inducible suppressor cells in regional lymph nodes of cancer patients.

Authors:  W J Catalona; T L Ratliff; R E McCool
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

9.  Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum.

Authors:  M I Greene; M E Dorf; M Pierres; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  5 in total

1.  Enhanced expression of lipocortin-1 as a new immunosuppressive protein in cancer patients and its influence on reduced in vitro peripheral blood lymphocyte response to mitogens.

Authors:  H Koseki; K Shiiba; Y Suzuki; T Asanuma; S Matsuno
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.

Authors:  A P van der Meijden; P A Steerenberg; I M van Hoogstraaten; J A Kerckhaert; L M Schreinemachers; E J Harthoorn-Lasthuizen; A M Hagenaars; W H de Jong; F M Debruijne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Relationship of the distribution of Leu-2+ cells with suppressor cell activities in the spleen and lymph-nodes from gastric cancer.

Authors:  T Toge; Y Seto; K Kuroi; H Yamada; K Aratani; T Fujita; E Yanagawa; T Hattori
Journal:  Jpn J Surg       Date:  1987-03

4.  Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy.

Authors:  W R Klein; P A Steerenberg; F Poelma; E vd Wiel; V P Rutten; W Misdorp; W H de Jong; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Role of the spleen on immunosuppression in esophageal and gastric cancer.

Authors:  T Toge; A Kameda; H Yamada; Y Seto; K Aratani; T Fujita; T Hattori
Journal:  Jpn J Surg       Date:  1986-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.